ClinicalTrials.gg
Not yet recruitingNCT07942844Updated Nov 17, 2026

Lumbar WBCT vs MRI

An observational study in Lumbar Radicular Pain and Lumbar Radiculopathy, sponsored by University of Kansas Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of Kansas Medical Center · Observational

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
90
Ages
45 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 127 studies in Radiculopathy with a site in United States — 30 open to participants now, 38 under way, 2 of them phase 3. Radiculopathy · United States.

Planned enrollment
8th of 21
90 · median 58
Started
2026
with 7 others
Observational
21 of 127
6 open now
Primary completion
2027-11
later than 28 of 37 live
Registered
127th of 127
by date

Among the 127 studies in Radiculopathy with a site in United States, this one is the 8th largest by planned enrollment of the 21 observational ones that give a count, is one of 8 that started in 2026, is one of 21 observational ones, reaches primary completion later than 28 of the 37 other live ones, and was the 127th registered.

Radiculopathy

484 studies on the registry are indexed under Radiculopathy; 144 are open to participants now.

Browse Radiculopathy studies →

Open to participants now

30 of the 127 studies in Radiculopathy with a site in United States are open now. Recruiting first, the newest first:

25 more — sign in →

All 30 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 79 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 48 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.

This study: 45 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 127 studies in Radiculopathy with a site in United States, or all of them as a file.
02

Study summary

Patients with pain in their low back that sometimes sends a shooting, sharp pain down their leg are usually diagnosed with lumbar radicular pain, or lumbar radiculopathy. MRIs are most commonly used to acquire images of the spine. The purpose of these images is to provide doctors with important information on what may be causing the low back pain and what treatment options may be the most effective in treating the pain. However, standard MRIs are taken when the patient is lying down, which may not be the most accurate representation of what the spine looks like in positions where patients experience pain, such as standing. A weight-bearing CT (WBCT) scan is a 3D imaging test that takes detailed pictures of the spine while patients are standing up. Unlike traditional MRI scans, where the patient lies down, this technology provides more information on how the spine looks when the patient is upright and participating in activities such as standing and walking. This information allows doctors to better understand the underlying causes of the pain and help guide targeted treatments to address those issues.

The Planmed XFI full-body weight-bearing CT scanner received 510(k) clearance from the FDA on September 26, 2025. This means the Planmed XFI® WBCT is safe and effective because it is substantially equivalent to a device already on the market.

Read the detailed description

Lumbar radicular pain and radiculopathy arise from heterogeneous mechanical and inflammatory processes affecting the lumbar nerve roots. Accurate localization of the symptomatic root determines the target of interventional and surgical treatment, and incorrect localization is a plausible contributor to procedural non-response. MRI is the principal imaging examination for suspected radiculopathy because it depicts the discs, nerve roots, and perineural fat. Its agreement with the clinically symptomatic root, however, is moderate at best. For the present study, a prospectively standardized, blinded, pre-imaging clinical phenotype serves as the operational reference standard. It is performed in every participant before any study imaging, locked before acquisition, and not revised afterward, so that imaging is scored against a fixed clinical target rather than reconciled with it. Across loaded and upright studies, mean positional effects on foraminal dimension are small and directionally mixed, and the literature is heterogeneous in device, posture, loading method, and outcome measure. Standing weight-bearing cone-beam CT provides three-dimensional isotropic imaging of the osseous foraminal boundary under physiological load, permitting quantitative cross-sectional area measurement in neutral and extension within a single session. Soft-tissue contrast is limited relative to MRI, which is why all primary measurements in this protocol are bony-boundary geometric measures. To our knowledge, no previous study has evaluated standing lumbar weight-bearing CT against a prospectively standardized, blinded, pre-imaging clinical phenotype. This study estimates that concordance, estimates whether it differs between neutral and standing extension, and characterizes the magnitude of positional change in foraminal dimension.

03

Conditions studied

  • Lumbar Radicular Pain
  • Lumbar Radiculopathy

Keywords

  • low back pain
  • lumbar radicular pain
  • lumbar radiculopathy
04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with lumbar radicular symptoms (unilateral or bilateral with clear unilateral dominance) identified from PM\&R spine clinic and affiliated clinics at KUMC.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥45 years.
  • Predominant unilateral lumbar radicular pain and/or paresthesias. True bilateral radicular presentations are excluded.
  • Lumbar radicular pattern on chart-review screening - a coarse eligibility filter only. Root level is not assigned at screening; it is assigned by the blinded standardized examination after enrollment (§8).
  • Ability to stand unsupported to undergo study examination and WBCT.
  • , including broad re-contact consent and consent to outcomes follow-up.

Exclusion criteria

Exclusion Criteria:

A candidate meeting any of the following is excluded:

  1. True bilateral or symmetric radicular presentation with no dominant symptomatic side. The side-contrast endpoint (§10.3) requires an asymptomatic homolog. Unilaterally dominant presentations with minor contralateral involvement are eligible; isolated laterality is recorded and drives a clean-unilateral sensitivity analysis.
  2. Radicular symptoms attributable to a non-degenerative cause - neoplasm, infection, inflammatory or disease, acute fracture, or other non-degenerative structural lesion at the symptomatic level.
  3. Any prior lumbar spine surgery - instrumented fusion, posterior instrumentation, decompression, or discectomy. Altered biomechanics, junctional change, and retained/residual disc or epidural fibrosis distort foraminal and segmental anatomy and confound both measurement and symptom attribution.
  4. Any lumbar spine procedure in the last 12 weeks - including any epidural injection, radiofrequency nerve ablation, facet injection, medial branch block or SI joint injection
  5. Inability to stand and hold the neutral and extension positions for acquisition with no more than light bilateral fingertip contact - from a balance disorder, orthostatic intolerance, lower-limb weakness, weight-bearing restriction, or pain that precludes positioning.
  6. Pregnancy or possibility of pregnancy. Screening and testing per institutional and RSO policy (§13).
  7. > 35 kg/m2. Cone-beam image quality degrades with soft-tissue path length independently of dose, and osseous depiction becomes diagnostically unusable in the 32-35 range (Benz 2018). Because the primary endpoint is a bony-boundary geometric measurement, quality loss translates directly into measurement error. Set pre-emptively rather than by post-acquisition exclusion, which would irradiate participants whose acquisitions are predictably unusable.
  8. Inability to provide , or insufficient capacity to understand and communicate symptoms for the standardized phenotype examination (§8).
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
90 participants (estimated)
Patient registry
No

Groups and cohorts

  • Lumbar WBCT

    Participants will be identified through chart-review screening. Eligible and enrolled participants will undergo a blinded, standardized clinical phenotype exam performed by an evaluator blinded to the chart-review call. The participant also will be asked to complete 4 participant-reported surveys (Oswestry Disability Index (ODI), pain numeric rating scale (NRS), patient-reported provocative posture, symptom duration). The participant then will undergo two WBCT scans, one in a neutral position and one in an extension position. These two scans will be performed in the same session.

    Device: Lumbar WBCT

Interventions

  • DeviceLumbar WBCT

    Participants will undergo two WBCT scans, one in a neutral position and one in an extension position.

06

What researchers measure

Primary outcomes

  1. Comparison of neutral WBCT position to prespecified clinical phenotype

    Estimate the proportion of participants in whom neutral standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype

    Time frame: From enrollment to end of visit at 1 day

Secondary outcomes

  1. Comparison of extension WBCT position to prespecified clinical phenotype

    Extension secondary. Estimate the proportion of participants in whom spinal extension standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype; to estimate the within-participant change in concordance between the neutral and extension acquisitions; and to estimate the within-participant side-contrast on each acquisition and its change between them.

    Time frame: From enrollment to end of visit at 1 day

  2. Comparison of standing WBCT to supine MRI images

    MRI secondary. In the MRI-available subset, compare standing WBCT and supine MRI concordance against the same clinical reference standard (paired; McNemar on discordant pairs).

    Time frame: From enrollment to end of visit at 1 day

  3. Comparison of electrodiagnostic (EDX) testing in WBCT vs MRI

    EDX secondary. In the EDX-available and EDX-positive subset, describe WBCT-EDX and MRI-EDX same-level same-side agreement.

    Time frame: From enrollment to end of visit at 1 day

07

Study locations

1 site
08

References and documents

Publications

  • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998 Apr 30;17(8):857-72. doi: 10.1002/(sici)1097-0258(19980430)17:83.0.co;2-e. PubMed 9595616 ↗
  • Whiting PF, Sterne JA, Westwood ME, Bachmann LM, Harbord R, Egger M, Deeks JJ. Graphical presentation of diagnostic information. BMC Med Res Methodol. 2008 Apr 11;8:20. doi: 10.1186/1471-2288-8-20. PubMed 18405357 ↗
  • Reimund JM, Allison AC, Muller CD, Dumont S, Kenney JS, Baumann R, Duclos B, Poindron P. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest. 1998 Feb;28(2):145-50. doi: 10.1046/j.1365-2362.1998.00257.x. PubMed 9541129 ↗
  • Kim YJ, Lee MY, Park HJ, Sohn E, Jeon WY, Yoo SR, Choi IS, Kim JH, Jeong SJ. Single oral toxicity assessment and phytochemical analysis of the Ficus erecta Thunb. Leaves extract. Toxicon. 2025 Jan;254:108219. doi: 10.1016/j.toxicon.2024.108219. Epub 2024 Dec 19. PubMed 39708945 ↗
  • Hoernschemeyer D, Farjoodi P, Cheng J, Sponseller P. A study of the cutaneous nerves encountered during thoracoplasty. Spine (Phila Pa 1976). 2007 Feb 1;32(3):301-5. doi: 10.1097/01.brs.0000253606.82387.96. PubMed 17268260 ↗
  • McDougall CG, Johnston SC, Gholkar A, Turk AS. Counterpoint-target aneurysm recurrence: measuring what matters. AJNR Am J Neuroradiol. 2015 Jan;36(1):4-6. doi: 10.3174/ajnr.A4205. Epub 2014 Nov 27. No abstract available. PubMed 25430860 ↗
  • Fukuhara T, Hild S, Zeiher J, Schauss P, Bloch I, Endres M, Gross C. Spatially Resolved Detection of a Spin-Entanglement Wave in a Bose-Hubbard Chain. Phys Rev Lett. 2015 Jul 17;115(3):035302. doi: 10.1103/PhysRevLett.115.035302. Epub 2015 Jul 13. PubMed 26230800 ↗
  • Thompson M. Towards an explanation of the Horwitz function. Anal Bioanal Chem. 2022 Feb;414(4):1671-1676. doi: 10.1007/s00216-021-03791-w. Epub 2021 Nov 25. PubMed 34821946 ↗
  • Marten T. Discussion of Shue et al. "Fat Injection: A Systemic Review of Injection Volumes by Facial Subunit". Aesthetic Plast Surg. 2018 Oct;42(5):1271-1276. doi: 10.1007/s00266-018-1168-0. Epub 2018 Jul 9. No abstract available. PubMed 29987483 ↗
  • Wisnieski L, Sanderson MW, Renter DG, Bello NM. Inferential implications of normalizing binomial proportions in a structural equation model: A simulation study motivated by feedlot data. Prev Vet Med. 2023 Aug;217:105963. doi: 10.1016/j.prevetmed.2023.105963. Epub 2023 Jun 13. PubMed 37385077 ↗
  • Haswell K, Gilmour J, Moore B. Clinical decision rules for identification of low back pain patients with neurologic involvement in primary care. Spine (Phila Pa 1976). 2008 Jan 1;33(1):68-73. doi: 10.1097/BRS.0b013e31815e3949. PubMed 18165751 ↗
  • Thudium CS, Rasmussen S, Karsdal MA, Bay-Jensen AC. Association between type III collagen degradation and local tissue damage of a single joint. Osteoarthr Cartil Open. 2024 Oct 12;6(4):100527. doi: 10.1016/j.ocarto.2024.100527. eCollection 2024 Dec. PubMed 39502930 ↗
  • Tovar-Guzman V, Hernandez-Giron C, Lopez-Rios O, Lazcano-Ponce EC. Prostate cancer mortality trends in Mexico, 1980-1995. Prostate. 1999 Apr 1;39(1):23-7. doi: 10.1002/(sici)1097-0045(19990401)39:13.0.co;2-i. PubMed 10221262 ↗
  • Raghavan R. Caring for Undocumented Immigrants With Kidney Disease. Am J Kidney Dis. 2018 Apr;71(4):488-494. doi: 10.1053/j.ajkd.2017.09.011. Epub 2017 Dec 1. PubMed 29198642 ↗
  • Dilley RA, McConnell DG. Alpha-tocopherol in the retinal outer segment of bovine eyes. J Membr Biol. 1970 Dec;2(1):317-23. doi: 10.1007/BF01869867. PubMed 24174154 ↗
  • Nunez-Gaona MA, Marcelin-Jimenez R, Gutierrez-Martinez J, Aguirre-Meneses H, Gonzalez-Compean JL. A Dependable Massive Storage Service for Medical Imaging. J Digit Imaging. 2018 Oct;31(5):628-639. doi: 10.1007/s10278-018-0091-x. PubMed 29777324 ↗
  • Rhodes T. Recalling items from a category for 1 hour: an inquiry into power-law behavior and memory foraging. Nonlinear Dynamics Psychol Life Sci. 2013 Jul;17(3):361-84. PubMed 23735492 ↗
  • Schiller ED, Maqsood MA, Pagel PS. Cardiac football or cause of severe tricuspid regurgitation? J Cardiothorac Vasc Anesth. 2010 Dec;24(6):1013-5. doi: 10.1053/j.jvca.2009.10.004. Epub 2009 Dec 16. No abstract available. PubMed 20005742 ↗
  • Albes J, Haverich A, Freihorst J, von der Hardt H, Manthey-Stiers F. Management of mycotic rupture of the ascending aorta after heart-lung transplantation. Ann Thorac Surg. 1990 Dec;50(6):982-3. doi: 10.1016/0003-4975(90)91139-3. PubMed 2146932 ↗
  • Vakulina TP, Poleshchuk VS, Pinelis VG, Markov KhM. [Delayed development of hypertension and increased aortic relaxation in spontaneously hypertensive rats after neonatal sympathectomy]. Biull Eksp Biol Med. 1987 May;103(5):526-9. Russian. PubMed 3036267 ↗
  • Bekkelund SI, Marthinsen TA, Harr T. Reversible dementia in idiopathic normal pressure hydrocephalus. A case report. Scand J Prim Health Care. 1999 Mar;17(1):22-4. doi: 10.1080/028134399750002845. PubMed 10229988 ↗
  • Chang FC, Lirng JF, Chen SS, Luo CB, Guo WY, Teng MM, Chang CY. Contrast enhancement patterns of acute spinal epidural hematomas: a report of two cases. AJNR Am J Neuroradiol. 2003 Mar;24(3):366-9. PubMed 12637283 ↗
  • Umesh SG, Malaiappan S. Caspase-3 Levels Alter With Non-surgical Periodontal Therapy in Patients With Periodontitis. Cureus. 2024 Feb 13;16(2):e54119. doi: 10.7759/cureus.54119. eCollection 2024 Feb. PubMed 38487123 ↗
  • Yuan BX, Chen LY, Wang WL, Li A, Xie XX, Duan WB, Liu RH. [Microcirculatory visualization and metabolomics of Dalbergia cochinchinensis in ameliorating coronary microvascular dysfunction in rats]. Zhongguo Zhong Yao Za Zhi. 2024 Apr;49(8):2247-2261. doi: 10.19540/j.cnki.cjcmm.20231121.301. Chinese. PubMed 38812239 ↗
  • Iosef C, Pedroza AJ, Cui JZ, Dalal AR, Arakawa M, Tashima Y, Koyano TK, Burdon G, Churovich SMP, Orrick JO, Pariani M, Fischbein MP. Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells. Sci Rep. 2020 Nov 23;10(1):20392. doi: 10.1038/s41598-020-77274-w. PubMed 33230159 ↗
  • Jiang J, Choi CMS, Thor M, Deasy JO, Veeraraghavan H. Tumor aware recurrent inter-patient deformable image registration of computed tomography scans with lung cancer. Med Phys. 2025 Feb;52(2):938-950. doi: 10.1002/mp.17536. Epub 2024 Nov 26. PubMed 39589333 ↗
  • Qiu J, Luo M, Dong J, Wang J, Li H, Wang X, Deng Y, Feng H, Deng X. Menthol diminishes Staphylococcus aureus virulence-associated extracellular proteins expression. Appl Microbiol Biotechnol. 2011 Apr;90(2):705-12. doi: 10.1007/s00253-011-3122-9. Epub 2011 Feb 2. PubMed 21287163 ↗
  • Porrino JA Jr, Kohl CA, Taljanovic M, Rogers LF. Diagnosis of proximal femoral insufficiency fractures in patients receiving bisphosphonate therapy. AJR Am J Roentgenol. 2010 Apr;194(4):1061-4. doi: 10.2214/AJR.09.3383. PubMed 20308511 ↗
  • Bae HW, Rajaee SS, Kanim LE. Nationwide trends in the surgical management of lumbar spinal stenosis. Spine (Phila Pa 1976). 2013 May 15;38(11):916-26. doi: 10.1097/BRS.0b013e3182833e7c. PubMed 23324922 ↗
  • Baskar R. Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis. Genome Integr. 2010 Sep 12;1(1):13. doi: 10.1186/2041-9414-1-13. PubMed 20831828 ↗
  • Li Q, Button-Simons KA, Sievert MAC, Chahoud E, Foster GF, Meis K, Ferdig MT, Milenkovic T. Enhancing Gene Co-Expression Network Inference for the Malaria Parasite Plasmodium falciparum. Genes (Basel). 2024 May 25;15(6):685. doi: 10.3390/genes15060685. PubMed 38927622 ↗
  • Sjoblom I, Nordstrom B, Edberg AK. A qualitative study of women's experiences of home birth in Sweden. Midwifery. 2006 Dec;22(4):348-55. doi: 10.1016/j.midw.2005.11.004. Epub 2006 May 26. PubMed 16730107 ↗
  • Arshad M, Bhatti A, John P, Jalil F, Borghese F, Kawalkowska JZ, Williams RO, Clanchy FIL. T cell activation Rho GTPase activating protein (TAGAP) is upregulated in clinical and experimental arthritis. Cytokine. 2018 Apr;104:130-135. doi: 10.1016/j.cyto.2017.10.002. Epub 2017 Oct 7. PubMed 29017772 ↗
  • Aili K, Campbell P, Michaleff ZA, Strauss VY, Jordan KP, Bremander A, Croft P, Bergman S. Long-term trajectories of chronic musculoskeletal pain: a 21-year prospective cohort latent class analysis. Pain. 2021 May 1;162(5):1511-1520. doi: 10.1097/j.pain.0000000000002137. PubMed 33230006 ↗
  • Murphy DR, Hurwitz EL, Gerrard JK, Clary R. Pain patterns and descriptions in patients with radicular pain: does the pain necessarily follow a specific dermatome? Chiropr Osteopat. 2009 Sep 21;17:9. doi: 10.1186/1746-1340-17-9. PubMed 19772560 ↗
  • Iversen T, Solberg TK, Romner B, Wilsgaard T, Nygaard O, Waterloo K, Brox JI, Ingebrigtsen T. Accuracy of physical examination for chronic lumbar radiculopathy. BMC Musculoskelet Disord. 2013 Jul 9;14:206. doi: 10.1186/1471-2474-14-206. PubMed 23837886 ↗
  • Tawa N, Rhoda A, Diener I. Accuracy of magnetic resonance imaging in detecting lumbo-sacral nerve root compromise: a systematic literature review. BMC Musculoskelet Disord. 2016 Sep 6;17(1):386. doi: 10.1186/s12891-016-1236-z. PubMed 27600883 ↗
  • Tawa N, Rhoda A, Diener I. Accuracy of clinical neurological examination in diagnosing lumbo-sacral radiculopathy: a systematic literature review. BMC Musculoskelet Disord. 2017 Feb 23;18(1):93. doi: 10.1186/s12891-016-1383-2. PubMed 28231784 ↗
  • Suri P, Hunter DJ, Katz JN, Li L, Rainville J. Bias in the physical examination of patients with lumbar radiculopathy. BMC Musculoskelet Disord. 2010 Nov 30;11:275. doi: 10.1186/1471-2474-11-275. PubMed 21118558 ↗
  • Suri P, Rainville J, Katz JN, Jouve C, Hartigan C, Limke J, Pena E, Li L, Swaim B, Hunter DJ. The accuracy of the physical examination for the diagnosis of midlumbar and low lumbar nerve root impingement. Spine (Phila Pa 1976). 2011 Jan 1;36(1):63-73. doi: 10.1097/BRS.0b013e3181c953cc. PubMed 20543768 ↗

Individual participant data

Plan to share: Undecided — If deidentified IPD is requested, for example for a meta-analysis or other study requiring those data, the investigators would provide those data.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 17, 2026
StartEst.
Nov 2026
Primary completionEst.
Nov 2027
CompletionEst.
Nov 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942844
Responsible party
Neil Segal, MD, MS (Director of Clinical Research, University of Kansas Medical Center) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 2026 (estimated)
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Jessica Lee, PhD
Contact
jlee33@kumc.edu
913-574-0958
Neil Segal, MD,MS
principal investigator · University of Kansas Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion